Search

Your search keyword '"Health Technology Assessment (HTA)"' showing total 350 results

Search Constraints

Start Over You searched for: Author "Health Technology Assessment (HTA)" Remove constraint Author: "Health Technology Assessment (HTA)" Topic 03 medical and health sciences Remove constraint Topic: 03 medical and health sciences
350 results on '"Health Technology Assessment (HTA)"'

Search Results

1. Understanding the Costs of Surgery

2. Broadening the application of health technology assessment in the Netherlands

3. Modeling Early Warning Systems

4. The Potential Cost-Effectiveness of a Cell-Based Bioelectronic Implantable Device Delivering Interferon-β1a Therapy Versus Injectable Interferon-β1a Treatment in Relapsing–Remitting Multiple Sclerosis

5. The Mental Health Quality of Life Questionnaire (MHQoL): development and first psychometric evaluation of a new measure to assess quality of life in people with mental health problems

6. Leveraging the Similarities Between Cost-Effectiveness Analysis and Value-Based Healthcare

7. Assessment of inflammatory bowel disease educational videos for increasing patient engagement and family and friends’ levels of understanding

8. Taking into Account Patient Preferences: A Consensus Study on the Assessment of Psychological Dimensions Within Patient Preference Studies

9. Preferences of patients and clinicians for treatment of Graves’ disease: a discrete choice experiment

10. The added value of H-2 antagonists in premedication regimens during paclitaxel treatment

11. A Head-to-Head Comparison of the Standard Quality-Adjusted Life Year Model With the Annual Profile Model

12. Innovative Medical Technology and the Treatment Decision-Making Process in Multiple Sclerosis: A Focus Group Study to Examine Patient Perspectives

13. Real-World Utilization of Biomarker Testing for Patients with Advanced Non–Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals

14. Do economic evaluations of TAVI consider learning effects, innovation, and context dependency?

15. Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands

16. Patient Preferences in Rare Diseases

17. Real-world healthcare costs of localized and regionally advanced cutaneous melanoma in the Netherlands

18. Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study

19. The potential of real-time analytics to improve care for mechanically ventilated patients in the intensive care unit: an early economic evaluation

20. Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)

21. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation

22. The Relative Importance of Education and Criminal Justice Costs and Benefits in Economic Evaluations: A Best–Worst Scaling Experiment

23. Assessment of Studies Evaluating Incremental Costs, Effectiveness, or Cost-Effectiveness of Systemic Therapies in Breast Cancer Based on Claims Data: A Systematic Review

24. Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines

25. Development of transferability guidance for integrated care models with special focus on central and Eastern European countries

26. Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer

27. Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis

28. CHANGING NURSING CARE TIME AS AN EFFECT OF CHANGED CHARACTERISTICS OF THE DIALYSIS POPULATION

29. Value of Information Analysis for Research Decisions—An Introduction

30. Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations

31. Summarizing Patient Preferences for the Competitive Landscape of (Multiple Sclerosis) Treatment Options

32. Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models

33. Patients', healthcare providers', and insurance company employees' preferences for knee and hip osteoarthritis care: a discrete choice experiment

34. Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab

35. Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients

36. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States

37. Exploring the Cost-Effectiveness of Mechanical Thrombectomy Beyond 6 Hours Following Advanced Imaging in the United Kingdom

38. How can we discover the most valuable types of big data and artificial intelligence-based solutions? A methodology for the efficient development of the underlying analytics that improve care

39. An implantable device to treat multiple sclerosis

40. Separating generalizable from source-specific preference heterogeneity in the fusion of revealed and stated preferences

41. Analysing electronic health records: The benefits of target trial emulation

42. Distributional consequences of including survivor costs in economic evaluations

43. Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry

44. Regulatory and HTA early dialogues in medical devices

45. Early palliative care associated with lower costs for adults with advanced cancer

46. Cost-utility analysis of four common surgical treatment pathways for breast cancer

47. Whole genome sequencing in oncology: using scenario drafting to explore future developments

48. Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands

49. The impact of a multimodal intervention on emergency department crowding and patient flow

50. Severity-Adjusted Probability of Being Cost Effective

Catalog

Books, media, physical & digital resources